Evidence map›Paper›PMID 29588269›Full record

ArticleJournal of medical Internet research2018

Developing a Shared Patient-Centered, Web-Based Medication Platform for Type 2 Diabetes Patients and Their Health Care Providers: Qualitative Study on User Requirements.

Gerda Bernhard, Cornelia Mahler, Hanna Marita Seidling, Marion Stützle, Dominik Ose, Ines Baudendistel, Michel Wensing, Joachim Szecsenyi

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Delineating and clarifying the concept of self-care monitoring: a concept analysis.International journal of qualitative studies on health and well-being · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Gerda BernhardDepartment of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0003-2622-0258
Cornelia MahlerDepartment of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-6601-0602
Hanna Marita SeidlingCooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-1215-634X
Marion StützleCooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-9143-7309
Dominik OseDepartment of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-5079-2152
Ines BaudendistelDepartment of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0001-5722-8004
Michel WensingDepartment of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0001-6569-8137
Joachim SzecsenyiDepartment of General Practice and Health Services Research, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0002-4483-0028
Heidelberg University · DEUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInformation technology tools such as shared patient-centered, Web-based medication platforms hold promise to support safe medication use by strengthening patient participation, enhancing patients' knowledge, helping patients to improve self-management of their medications, and improving communication on medications among patients and health care professionals (HCPs). However, the uptake of such platforms remains a challenge also due to inadequate user involvement in the development process. Employing a user-centered design (UCD) approach is therefore critical to ensure that user' adoption is optimal.

objectiveThe purpose of this study was to identify what patients with type 2 diabetes mellitus (T2DM) and their HCPs regard necessary requirements in terms of functionalities and usability of a shared patient-centered, Web-based medication platform for patients with T2DM.

methodsThis qualitative study included focus groups with purposeful samples of patients with T2DM (n=25), general practitioners (n=13), and health care assistants (n=10) recruited from regional health care settings in southwestern Germany. In total, 8 semistructured focus groups were conducted. Sessions were audio- and video-recorded, transcribed verbatim, and subjected to a computer-aided qualitative content analysis.

resultsAppropriate security and access methods, supported data entry, printing, and sending information electronically, and tracking medication history were perceived as the essential functionalities. Although patients wanted automatic interaction checks and safety alerts, HCPs on the contrary were concerned that unspecific alerts confuse patients and lead to nonadherence. Furthermore, HCPs were opposed to patients' ability to withhold or restrict access to information in the platform. To optimize usability, there was consensus among participants to display information in a structured, chronological format, to provide information in lay language, to use visual aids and customize information content, and align the platform to users' workflow.

conclusionsBy employing a UCD, this study provides insight into the desired functionalities and usability of patients and HCPs regarding a shared patient-centered, Web-based medication platform, thus increasing the likelihood to achieve a functional and useful system. Substantial and ongoing engagement by all intended user groups is necessary to reconcile differences in requirements of patients and HCPs, especially regarding medication safety alerts and access control. Moreover, effective training of patients and HCPs on medication self-management (support) and optimal use of the tool will be a prerequisite to unfold the platform's full potential.

Indexed as

Drug MonitoringAgedDiabetes Mellitus, Type 2Focus GroupsHealth PersonnelHumansInternetMiddle AgedPatient ParticipationPatient PortalsQualitative Researchfocus groupsmedicationpatient participationpatient portalprimary careself-managementtype 2 diabetes mellitus

Identifiers

PMID29588269
PMCPMC5893891
OpenAlexW2795247856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.